trial · primary record
vorinostat
Male Breast Cancer
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2019-09-27 |
| Primary endpoint | Dose limiting toxicity defined as any treatment-related grade 3 or greater non-hematologic toxicity, grade 4 febrile neutropenia, thrombocytopenia or grade 4 neutropenia as a result of unresolved toxicity |
| Registry ID | NCT01084057 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:24.334Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01084057
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.